Table 1.
Activity | Species | Experiment setting | Key findings | Refs |
---|---|---|---|---|
Anti-coagulant and Anti-thrombotic | Fucus vesiculosus; Undaria pinnatifida; Fucus evanescens | immobilized on plasma treated PET; in vitro anticoagulant assay | prolonged TT and APTT | (Kim et al., 2010; Kuznetsova et al., 2003; Ozaltin et al., 2019; Zhang et al., 2015) |
Laminaria hyperborean | lepirudin-based human whole blood model in vitro anticoagulant assay; in | inhibited coagulation above 100 μg/mL; stimulated coagulation at 10 μg/mL slowed thrombosis formation, increased | (Kopplin et al., 2018) | |
Saccharina japonica | vivo arterial thrombosis rat model; oral administration in human | TFPI; prolonged APTT and TT; inhibited thrombin-induced platelet aggregation; shortened lysis time of thrombus | (Ren et al., 2013; Zhang et al., 2015; Zhao et al., 2012; Zhao et al., 2016) | |
Ecklonia maxima | in vitro anticoagulant assay | increased APTT | (Zhang et al., 2015) | |
Ecklonia cava | in vitro anticoagulant assay | prolonged bleeding time | (Wijesinghe et al., 2011) | |
Hizikia fusiforme | in vitro anticoagulant assay | prolonged APTT distinctly, but delayed TT little | (Li, Zhao, et al., 2008) | |
Ascophyllum nodosum | in vitro anticoagulant assay | bound to antithrombin in a 1:1 stoichiometry | (Varenne, Gareil, Colliec-Jouault, & Daniel, 2003) | |
Turbinaria conoides | in vitro anticoagulant assay | prolonged both APTT and PT | (Ganapathy et al., 2019) | |
Holothuria edulis; Ludwigothurea grisea | in vitro anticoagulant assay | prolonged APTT, but not PT nor TT; inhibited thrombin and factor Xa | (Wu et al., 2015) | |
Holothuria polii | in vitro anticoagulant assay | inhibited thrombin with the presence of heparin cofactor II and antithrombin III | (Mansour et al., 2019) | |
Isostichopus badionotus | in vitro anticoagulant assay | improved antithrombin activity on thrombin and factor Xa | (Chen et al., 2012) | |
Platelet | Fucus vesiculosus | in vitro platelet rich plasma | induced irreversible platelet aggregation and activation through SFK-dependent pathways; increased CD62p and CD63 positive platelets | (Carvalho G. de Azevedo et al., 2009; Dürig et al., 1997; Kardeby et al., 2019; Manne et al., 2013) |
Saccharina japonica | in vivo intravenous injection of LMWF at 10 mg/kg | inhibit activation of platelets by reducing platelet aggregation | (Chen et al., 2016; Zhu et al., 2010) | |
Holothuria edulis; Ludwigothurea grisea | in vitro citrated human platelet rich plasma; | did not induce platelet aggregation at various concentrations (7.5–30 μg/mL) | (Wu et al., 2015) | |
Anti-complement | Saccharina japonica; Sargassum thunbergii | in vitro | anticomplement activity | (Jin, Liu, Zhong, Sun, & Zhang, 2017; Liu et al., 2018) |
Laminaria hyperborea | lepirudin-based human whole blood model | sulfation and high molecular weight are important in anticomplement activity | (Kopplin et al., 2018) | |
Saccharina latissimi; Fucus vesiculosus | in vitro | reduced IL-8 and C5a-induced calcium release by binding to IL-8 and C5a in a concentration-dependent manner | (Liewert, Ehrig, & Alban, 2017) | |
Ascophyllum nodosum | MALDI-TOF mass spectroscopy; in vitro hemolytic assay in whole serum | bound to C1q; blocked the dissociation of C2 and C4, to a lesser extent of C3 | (Clément et al., 2010; Tissot, Daniel, et al., 2003; Tissot et al., 2005; Tissot, Montdargent, et al., 2003) | |
Laminaria cichorioides; fucus evanescens | in vitro assay with human serum | caused 50% inhibition of alternative pathway of complement | (Zvyagintseva et al., 2000) | |
Inhibit selectin | Sargassum fusiforme | in vitro static and flow chamber | blocked P-selectin mediated adhesion of neutrophil | (Wu et al., 2019) |
Saccharina japonica | diabetic nephropathy rat | decreased the level of P-selectin and selectin-dependent inflammatory cytokines | (Xu, Zhang, Luo, Wang, & Duan, 2016) | |
Sacharina latissima | in vitro binding activity | inhibited L- and P-selectin | (Ushakova et al., 2005) | |
Endothelial cells | Fucus vesiculosus; Ascophyllum nodosom | layer-by-layer stent coating with laminin; polyvinyl alcohol hydrogels; decellularized pulmonary heart valve | promoted endothelial cell adhesion and proliferation | (Marinval et al., 2018; Yao et al., 2020; Ye et al., 2016) |
Fucus evanescens | dyslipidemia mice model | reduced levels of endothelin-1 and TNFα, IFNγ in blood serum. | (Kuznetsova et al., 2019) | |
Ascophyllum nodosom | EPC proliferation and adhesion; in vitro tube formation assay | promoted proangiogenic phenotype, proliferation and migration of EPCs | (Roux et al., 2012) | |
Undaria piniatifida | HUVEC proliferation, migration, and tube formation | reduced HUVEC proliferation and migration; inhibited tube formation | (Liu et al., 2012) | |
Anti-proliferation | Fucus vesiculosus | in vitro cell culture; in vivo injection; fucoidan coated stent | inhibited SMC proliferation and migration; interacted with TGF-β1; reduced restenosis | (Kim et al., 2015; McCaffrey et al., 1992; Novoyatleva et al., 2019; Religa et al., 2000) |
Saccharina japonica | in vitro cell culture; in vivo in ApoE (−/−) mouse model | inhibited SMC proliferation and migration; reduced atherosclerosis | (Xu et al., 2019) | |
Undaria pinnatifida | in vivo in eNOS inhibition-induced hypertensive rat model | reduced media thickening and SMC proliferation | (Li et al., 2016) | |
Ascophyllum nodosum | in vitro cell culture; balloon-induced thoracic aorta injury rat model | inhibited SMC growth and migration; inhibited collagen synthesis; reduced intimal hyperplasia | (Hlawaty et al., 2011; Logeart et al., 1996) |
The extended version of the table is provided in the Supplementary Table 1